Can microdosing psilocybin be used to treat chronic pain?
A recent series of case studies provided promising preliminary evidence for the potential of microdosing in treating chronic pain.
A recent series of case studies provided promising preliminary evidence for the potential of microdosing in treating chronic pain.
At the federal level, psilocybin in listed as a Schedule I drug. The use, sale, and possession of psilocybin in
Currently, there is no empirical evidence available that supports the absorption of psychedelic compounds such as psilocybin through skin pores.
To date, there is currently limited-to-no available evidence-based knowledge on dosage method comparisons for microdosing.
Psychedelic integration is a critical component of understanding and incorporating the knowledge and lessons gained during the psychedelic experience.
HPPD is a rare clinical condition that results in people experience visual and perceptual distortions days, months, or even years
©2025 Unlimited Sciences. All rights reserved.
We hate pop-ups as much as you do, but if you want to stay up to date about the latest news in the psychedelic space and learn about our ground-breaking psychedelic research, please consider signing up for our newsletter below.